Navigation Links
Acetaldehyde in alcohol -- no longer just the chemical that causes a hangover
Date:3/19/2009

tist of the Toronto group and head of the Public Health and Regulatory Policies section at CAMH. "This has led to a negligence of the overall risk."

For example, in Toronto, even though there are limits for air exposure of acetaldehyde set by the responsible Public Health agency, these limits have been surpassed in the past. Alone, the risks associated with surpassing limits of acetaldehyde from the air may not yet be alarming, but for heavy drinkers and smokers, it adds to the acetaldehyde levels already received from these sources. This overall risk then surpasses established safety limits.

"Their risk assessment of acetaldehyde present as a congener in alcoholic beverages touches the tip of the iceberg," according to a Commentary on the CAMH/CVUA study in the journal Addiction.

Based on their study the scientists of CAMH recommend:

  • That the classification of acetaldehyde with respect to cancer be re-examined, incorporating new evidence which points to an additional cancer risk to humans.
  • That a further risk assessment should take into consideration all sources of exposure from this substance.
  • That the risk for cancer stemming from acetaldehyde from alcoholic beverages is recognized, and necessary preventive steps are taken to reduce the acetaldehyde content in alcoholic beverages.
  • That the overall level of acetaldehyde exposure be minimized to the lowest level technically possible.


'/>"/>

Contact: Michael Torres
michael_torres@camh.net
416-595-6015
Centre for Addiction and Mental Health
Source:Eurekalert

Page: 1 2

Related medicine news :

1. The Recovery Place Helps Hundreds of Patients Through Drug and Alcohol Rehabilitation
2. Affordable Drug and Alcohol Rehab Ranch Residence is Saving Lives in Washington
3. Shootings Linked to Alcohol-to-Go Outlets, Study Finds
4. The Rev. Joseph C. Martin, Leading Authority on Alcoholism and Addiction Treatment, Dies at 84
5. Media Images of Alcohol Can Drive You to Drink
6. Alcohol consumption may increase pancreatic cancer risk
7. Owning alcohol-branded merchandise associated with teen drinking behaviors
8. Is telmisartan effective in treating non-alcoholic steatohepatitis?
9. Alcohol-Branded Apparel Linked to Adolescent Drinking
10. Alcohol types and socioeconomic status are associated with Barretts esophagus risk
11. Million women study shows even moderate alcohol consumption associated with increased cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , PEMBROKE, Bermuda, Dec. 4 /PRNewswire-Fi...s, Ltd (NYSE: AWH ) today announced that Scott C...nd Jack Sennott, Executive Vice,President and Chie...t the 2009,Goldman Sachs U.S. Financial Services C...ce Center in New York City on Tuesday, December 8,...
(Date:12/4/2009)..., KANSAS CITY, Mo., Dec. 4 The ... National Association of Free Clinics (NAFC) in Ka...r the sick but also for anyone who is uninsured an... in the health clinic will receive preventive prim...ee previous large free clinic events this fall in ...
(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ -...m would control health care costs, Leapfrog,s purc...ugh example -- delivering the best quality care in...efficiency. Thirty-four urban, eight children,s an...rog Top Hospitals, based on results from The Leapf...
(Date:12/4/2009)... STANFORD, Calif. A new study shows that muscle ...ability to squeeze shut properly. The work, perfor...patients with conditions such as gastric reflux an...ed to strengthen sphincters, which are the bands o...intestinal tract. Weakness in these areas can caus...
(Date:12/4/2009)... than 15 million Americans are recruited annually ... Alliance for Human Research Protection (AHRP), an.... , Research institutions view payments to v...ot as compensation for potential risks related to ... finds that volunteers have a very different view ...
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2
...nologies Inc., a,leading developer and manufacture...today announced that the company has entered into ... with LightLab imaging.,Under this multi- year exc... system., (Photo: http://www.newscom.com/cgi-bin...
.... (San Francisco, CA,and Ottawa, Canada), announce...delivered a plenary session presentation on Friday... with JX-594, a Novel Targeted,Multi-Mechanistic O...his abstract was selected for presentation in the,...
...ata Demonstrating Superiority of XIENCE ...KYO, June 2 Abbott (NYSE: ABT ) today,announced ...bai Shonin,(Marketing Authorization License) to Ja...s Eluting Coronary Stent System to,treat coronary ...
...(OTC,Bulletin Board: IAGX) announced today that it...aVie LLC (http://www.monavie.com ) that provides ... Celadrin, a cellular lubricant, is a joint healt...ty.,Celadrin is a unique, scientifically arranged ...
...k II anaerobic,system for the cultivation of anaer... an excellent alternative to the use of anaerobic ...aboratories. The Anoxomat Mark II,automatic jar ev...the way the Anoxomat jar works, I can open it up, ...
..., kept tumors stable for almost 6 months , ...n therapy of gemcitabine, capecitabine and bevaciz...ancreatic cancer, according to a multi-center stud...ated by patients, was able to prevent tumors from ...
Other Medicine News:Health News:Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging 2Health News:Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference 2Health News:Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference 3Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 2Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 3Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 4Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 5Health News:Imagenetix Enters into Business Relationship with MonaVie 2Health News:Advanced Instruments' Anoxomat Mark II Anaerobic System is Excellent Alternative to Anaerobic Chambers, Gas Bags in Clinical Laboratories 2Health News:Advanced Instruments' Anoxomat Mark II Anaerobic System is Excellent Alternative to Anaerobic Chambers, Gas Bags in Clinical Laboratories 3
(Date:12/4/2009)... , MORRISTOWN, N.J., Dec. 4 /PRNewswire-FirstC...), a leading global specialty pharmaceutical compa...boratories, Inc.-Florida, filed an Abbreviated New...ug Administration seeking approval to market its 8...patent owned by Takeda Pharmaceutical Company Limi...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 /PRNewswire-FirstCa...that the US Food and Drug Administration (FDA) has... fumarate) Extended Release Tablets as adjunctive ...th Major Depressive Disorder (MDD). SEROQUEL XR is...FDA to treat both major depressive disorder as adj...
(Date:12/3/2009)... , ALISO VIEJO, Calif. and STATE COLLEGE, Pa.,...etics today announced the signing of an agreement ...es using SoftGenetics, NextGENe software for next-... ,, (Logo: http://www.newscom.com/cgi-bin/p...PhD, Ambry,s CSO said, "Our team at Ambry has been...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 1Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 2Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 3Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 4Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 5Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 6Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 7Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 8Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 1Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 2Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 3HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 1HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 2HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 3
Complete brand Blink-N-Clean Lens Drops
Renu Preservative Free Lubricating and Rewetting Drops
Sterile Preserved Saline Solution
Sensitive Eyes Plus Saline Solution
Medicine Products: